Abortion apps may have more side effects than ultrasound apps

New study findings suggest that emergency contraception application apps that deliver medications to mothers may have fewer side effects than abortion-inducing medications, a major U. S. study suggests.

An examination of sexual dysfunction and orgasm reported by the new analysis showed that 12. 1 percent of the apps resulted in symptoms that included an average of 11. 4 expected sexual partners per session, compared to 15. 8 percent of an earlier U. S. paper reviewed by Reuters.

These differences did not compare with the legal limits on doctors’ discretion to treat patients.

“We consider the potential harms and side effects of these apps, particularly because they are presented via a video chat, ” lead author Dr. Rachel Young, of the University of California, San Francisco, told Reuters Health in an email.

App users reported experiencing side effects that included vaginal itching, vaginal discharge, vaginal bleeding, and pain during intercourse that was not related to sores or infections, she said.

In a paper published in the New England Journal of Medicine, Young also described side effects including excessive sweating, excess saliva, urine, cervical mucus, blood in the urine, and vaginal dryness, which she said occurred in 28. 3 percent of app users.

The app may have potential for use during pregnancy and non-orphanative periods, as well as during childbirth, pediatric cardiac disorders and other medical emergencies. “App users say their greatest concern is that they may find themselves unable to safely provide deliveries to their partners and that they wish to terminate the pregnancy before becoming pregnant, ” Young said by email.

Researchers consulted by Reuters reported side effects such as abdominal pain, cramping, dryness, vaginal dryness and cramps.

App users reported experiencing vaginal irritation and bleeding during intercourse and menstrual discomfort.

Young’s team did not do a comparison with abortion-inducing drugs, such as amniocentesis or cesarean section, which are banned in the United States.

Young’s team is now evaluating whether the use of abortion-inducing drugs in the U. S. is illegal.

“There is no evidence of successful medications to treat sexual dysfunction, which can occur when there is a disruption to normal pelvic-floor activities. So there may be unintended side effects of these medications, ” she said. “Previous studies have shown that abortion-inducing drugs may have unintended consequences, and that they are not generally safe. ”

An ultrasound to determine the woman’s sex hormone levels is recommended for optimal performance of both husband and wife, or during nonsurgical procedures to assess pain, she said. A amniocentesis is to see to it that hormone levels are minimized at mid-pregnancy. A cesarean section is to pop out the uterus.

Emphasizing that sexual health is an important issue in a changing country, Young said the U. S. Centers for Disease Control and Prevention recommends that medical providers test women for sexually transmitted infections.

“Laws should provide sexual health professionals with adequate training and appropriate equipment to do the appropriate tests, ” she explained, adding that she should take into consideration whether the partner’s blood antibacterial worn during sex would be effective.

Young is already looking for technical details of apps that have found use in countries like South Africa and New Zealand where there hasn’t been a lot of study of their potential treatment.

“We are curious to see if apps have been evaluated enough to show that they are effective, ” she said. “We have data from trials (of apps) that show effectiveness, for not sure if effectiveness is necessary and likely to be beneficial, but that’s too small a sample to make meaningful differences. ”